Impact of ranolazine on ventricular arrhythmias – A systematic review

Ranolazine is a new medication for the treatment of refractory angina. However, except its anti‐anginal properties, it has been found to act as an anti‐arrhythmic. The aim of our systematic review is to present the existing data about the impact of ranolazine in ventricular arrhythmias. We searched...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Arrhythm
Main Authors: Bazoukis, George, Tse, Gary, Letsas, Konstantinos P., Thomopoulos, Costas, Naka, Katerina K., Korantzopoulos, Panagiotis, Bazoukis, Xenophon, Michelongona, Paschalia, Papadatos, Stamatis S., Vlachos, Konstantinos, Liu, Tong, Efremidis, Michael, Baranchuk, Adrian, Stavrakis, Stavros, Tsioufis, Costas
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2018
Assuntos:
Clinical Reviews
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5891418/
https://ncbi.nlm.nih.gov/pubmed/29657587
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/joa3.12031
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares